INTRA-CELLULAR THERAPIES INC (ITCI) Stock Analyst Earnings Estimates
NASDAQ:ITCI - Nasdaq - US46116X1019 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 250.3M 198.69% | 464.37M 85.53% | 680.852M 46.62% | 966.26M 41.92% | 1.566B 62.07% | 2.215B 41.44% | 2.757B 24.47% | 3.385B 22.78% | 3.525B 4.14% | 3.797B 7.72% | 4.056B 6.82% | |
| EBITDA YoY % growth | -262.94M 7.80% | -158.853M 39.59% | -116.213M 26.84% | 29.026M 124.98% | 491.43M 1,593.07% | 1.174B 138.89% | 1.85B 57.58% | 2.487B 34.43% | 2.83B 13.79% | 3.07B 8.48% | 3.279B 6.81% | |
| EBIT YoY % growth | -263.6M 7.74% | -159.381M 39.54% | -116.721M 26.77% | -11.62M 90.04% | 442.48M 3,907.87% | 1.066B 140.91% | 1.669B 56.57% | 2.166B 29.78% | 2.274B 4.99% | 2.721B 19.66% | 2.883B 5.95% | |
| Operating Margin | -105.31% | -34.32% | -17.14% | -1.20% | 28.26% | 48.13% | 60.54% | 63.99% | 64.51% | 71.66% | 71.08% | |
| EPS YoY % growth | -2.72 22.29% | -1.46 46.32% | -0.73 50.00% | 0.20 127.35% | 4.03 1,917.44% | 8.72 116.50% | 10.81 24.01% | 15.25 41.06% | 15.57 2.06% | 16.79 7.86% | 17.66 5.16% |
All data in USD
| Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.11 33.06% | -0.03 81.94% | 0.02 109.79% | 0.20 227.50% |
| Revenue Q2Q % growth | 210.57M 45.36% | 226.45M 40.31% | 243.42M 38.80% | 279.79M 40.44% |
| EBITDA Q2Q % growth | -12.985M 37.63% | -4.57M 83.36% | -9.353M 75.67% | -12.138M 57.69% |
| EBIT Q2Q % growth | -19.846M 5.28% | -12.401M 55.27% | -496.23K 98.72% | 20.925M 171.67% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | -0.16 46.67% | -0.11 | -0.05 | -40.63% |
| Q3 2024 Q2Q % growth | -0.25 | -0.20 | -0.05 | -24.97% |
| Q2 2024 Q2Q % growth | -0.16 64.44% | -0.19 | 0.03 | 17.50% |
| Q1 2024 Q2Q % growth | -0.16 65.22% | -0.32 | 0.16 | 50.59% |
| Q4 2023 Q2Q % growth | -0.30 33.33% | -0.45 | 0.15 | 33.56% |
| Q3 2023 Q2Q % growth | -0.25 56.14% | -0.58 | 0.33 | 56.70% |
| Q2 2023 Q2Q % growth | -0.45 51.09% | -0.60 | 0.15 | 25.25% |
| Q1 2023 Q2Q % growth | -0.46 41.03% | -0.62 | 0.16 | 25.60% |
| Q4 2022 Q2Q % growth | -0.45 57.14% | -0.60 | 0.15 | 25.52% |
| Q3 2022 Q2Q % growth | -0.57 40.00% | -0.83 | 0.26 | 31.36% |
| Q2 2022 Q2Q % growth | -0.92 -8.24% | -0.78 | -0.14 | -18.61% |
| Q1 2022 Q2Q % growth | -0.78 -20.00% | -0.94 | 0.16 | 16.92% |
| Q4 2021 Q2Q % growth | -1.05 -38.16% | -1.01 | -0.04 | -3.56% |
| Q3 2021 Q2Q % growth | -0.95 -20.25% | -0.94 | -0.01 | -1.24% |
| Q2 2021 Q2Q % growth | -0.85 11.46% | -0.81 | -0.04 | -5.34% |
| Q1 2021 Q2Q % growth | -0.65 10.96% | -0.82 | 0.17 | 20.47% |
| Q4 2020 Q2Q % growth | -0.76 -2.70% | -0.86 | 0.10 | 11.88% |
| Q3 2020 Q2Q % growth | -0.79 -25.40% | -1.02 | 0.23 | 22.24% |
| Q2 2020 Q2Q % growth | -0.96 -41.18% | -0.93 | -0.03 | -3.57% |
| Q1 2020 Q2Q % growth | -0.73 -15.87% | -0.95 | 0.22 | 22.77% |
| Q4 2019 Q2Q % growth | -0.74 | -0.85 | 0.11 | 12.70% |
| Q3 2019 Q2Q % growth | -0.63 | -0.83 | 0.20 | 23.84% |
| Q2 2019 Q2Q % growth | -0.68 | -0.84 | 0.16 | 19.14% |
| Q1 2019 Q2Q % growth | -0.63 | -0.89 | 0.26 | 29.41% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 199.223M 50.81% | 197.26M | 1.963M | 1.00% |
| Q3 2024 Q2Q % growth | 175.375M 39.00% | 175.8M | -425K | -0.24% |
| Q2 2024 Q2Q % growth | 161.388M 45.67% | 161.04M | 348K | 0.22% |
| Q1 2024 Q2Q % growth | 144.866M 52.00% | 144.21M | 656K | 0.45% |
| Q4 2023 Q2Q % growth | 132.099M 50.28% | 138.38M | -6.281M | -4.54% |
| Q3 2023 Q2Q % growth | 126.173M 75.48% | 121.62M | 4.553M | 3.74% |
| Q2 2023 Q2Q % growth | 110.792M 99.27% | 108.78M | 2.012M | 1.85% |
| Q1 2023 Q2Q % growth | 95.306M 172.30% | 93.824M | 1.482M | 1.58% |
| Q4 2022 Q2Q % growth | 87.9M 242.02% | 88.711M | -811K | -0.91% |
| Q3 2022 Q2Q % growth | 71.9M 223.87% | 67.324M | 4.576M | 6.80% |
| Q2 2022 Q2Q % growth | 55.6M 178.00% | 50M | 5.6M | 11.20% |
| Q1 2022 Q2Q % growth | 35M 120.13% | 34.325M | 675K | 1.97% |
| Q4 2021 Q2Q % growth | 25.7M 105.60% | 25.458M | 242K | 0.95% |
| Q3 2021 Q2Q % growth | 22.2M 200.00% | 22.559M | -359K | -1.59% |
| Q2 2021 Q2Q % growth | 20M 952.63% | 19.416M | 584K | 3.01% |
| Q1 2021 Q2Q % growth | 15.9M 1,345.45% | 16.834M | -934K | -5.55% |
| Q4 2020 Q2Q % growth | 12.5M 12,400.00% | 12.076M | 424K | 3.51% |
| Q3 2020 Q2Q % growth | 7.4M | 5.981M | 1.419M | 23.73% |
| Q2 2020 Q2Q % growth | 1.9M | 2.971M | -1.071M | -36.05% |
| Q1 2020 Q2Q % growth | 1.1M | 1.469M | -369K | -25.12% |
| Q2 2019 Q2Q % growth | 11.332K | -11.332K | -100.00% | |
| Q1 2019 Q2Q % growth | 12.75K | -12.75K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 42.86% | -30.48% | -47.79% |
| Revenue | 0% | 4.15% | 0.91% | 1.41% |